9-Bromo-2-(naphthalen-2-yl)-1,10b-dihydrospiro[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,1'-cyclohexane]

Catalog No. :
ACUCNU744
CAS No. :
303060-56-2
Molecular Formula :
C25H23BrN2O
Molecular Weight :
447.38

IUPAC Name:9-bromo-2-(naphthalen-2-yl)-1,10b-dihydrospiro[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,1'-cyclohexane]

9-Bromo-2-(naphthalen-2-yl)-1,10b-dihydrospiro[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,1'-cyclohexane] structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-Bromo-2-(naphthalen-2-yl)-1,10b-dihydrospiro[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,1'-cyclohexane]
IUPAC Name9-bromo-2-(naphthalen-2-yl)-1,10b-dihydrospiro[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,1'-cyclohexane]
Molecular FormulaC25H23BrN2O
Molecular Weight447.38
SMILESBrC1=CC=C(OC2(CCCCC2)N3C4CC(C5=CC=C6C=CC=CC6=C5)=N3)C4=C1
InChI KeyKGVFHFPUOPVGQI-UHFFFAOYSA-N
Synonym12'-bromo-4'-(naphthalen-2-yl)-8'-oxa-5',6'-diazaspiro[cyclohexane-1,7'-tricyclo[7.4.0.0^{2,6}]tridecane]-1'(9'),4',10',12'-tetraene;Spiro[cyclohexane-1,5'-[5H]pyrazolo[1,5-c][1,3]benzoxazine], 9'-bromo-1',10'b-dihydro-2'-(2-naphthalenyl)-;9-BROMO-2-(NAPHTHALEN-2-YL)-1,10B-DIHYDROSPIRO[BENZO[E]PYRAZOLO[1,5-C][1,3]OXAZINE-5,1'-CYCLOHEXANE];9-BROMO-2-(NAPHTHALEN-2-YL)-1,10B-DIHYDROSPIRO[BENZO[E]PYRAZOLO[1,5-C][1,3]OXAZINE-5,1'-CYCLOHEXANE]
CAS No.303060-56-2

Synthetic Route by SureRoute

1. ACUCNU744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUCNU744 route product structure diagram
    ACUCNU744303060-56-2
Inquiry

2. ACUCNU744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUCNU744 route product structure diagram
    ACUCNU744303060-56-2
Inquiry

Comments (0)